NEBIVOLOL/AE - Search Results

Year	Number of Results
2015	4
2016	3
2017	5
2018	5
2020	2
2021	4
2022	2
2023	1
2024	2
2025	4

1

Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease.

AlHabeeb W, Mrabeti S, Abdelsalam AAI. AlHabeeb W, et al. Cardiovasc Drugs Ther. 2022 Oct;36(5):959-971. doi: 10.1007/s10557-021-07205-y. Epub 2021 Jun 9. Cardiovasc Drugs Ther. 2022. PMID: 34106365 Free PMC article. Review.

2

A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension.

Cicero AFG, Kuwabara M, Borghi C. Cicero AFG, et al. Drugs. 2018 Nov;78(17):1783-1790. doi: 10.1007/s40265-018-0999-y. Drugs. 2018. PMID: 30426333

3

A Review of Nebivolol Pharmacology and Clinical Evidence.

Fongemie J, Felix-Getzik E. Fongemie J, et al. Drugs. 2015 Aug;75(12):1349-71. doi: 10.1007/s40265-015-0435-5. Drugs. 2015. PMID: 26177892 Free PMC article. Review.

4

Effect of nebivolol on erectile function: a systematic review and meta-analysis of randomized controlled trials.

Lu Y, Li L, Li Q, Sun G. Lu Y, et al. J Sex Med. 2025 Jan 9;22(2):307-316. doi: 10.1093/jsxmed/qdae189. J Sex Med. 2025. PMID: 39713902

5

Nebivolol/valsartan: Fixed-dose combination for treatment of hypertension.

Paton DM. Paton DM. Drugs Today (Barc). 2017 Jan;53(1):19-26. doi: 10.1358/dot.2017.53.1.2560078. Drugs Today (Barc). 2017. PMID: 28387384 Review.

6

Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension.

Li B, Zhang Q, Zhang H, Wang C, Xiu R. Li B, et al. Biosci Rep. 2020 May 29;40(5):BSR20200436. doi: 10.1042/BSR20200436. Biosci Rep. 2020. PMID: 32342981 Free PMC article. Review.

7

Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials.

Manolis A, Karakasis P, Patoulias D, Doumas M, Kallistratos M, Thomopoulos C, Koutsaki M, Grassi G, Mancia G. Manolis A, et al. High Blood Press Cardiovasc Prev. 2025 Jan;32(1):7-31. doi: 10.1007/s40292-024-00687-5. Epub 2024 Oct 29. High Blood Press Cardiovasc Prev. 2025. PMID: 39467996

8

Nebivolol/Valsartan (Byvalson) for Hypertension.

Lamberton NH, Copenhaver AM. Lamberton NH, et al. Am Fam Physician. 2018 Jan 15;97(2):124-125. Am Fam Physician. 2018. PMID: 29365224 Free article. No abstract available.

9

Nebivolol hydrochloride and its impurities induce pseudo-allergic reactions via mast cell activation.

Yu L, Shan Y, Lu J, He H. Yu L, et al. J Appl Toxicol. 2025 Feb;45(2):266-272. doi: 10.1002/jat.4699. Epub 2024 Sep 16. J Appl Toxicol. 2025. PMID: 39285676

10

Nebivolol Induced Hyperkalemia: Case Report.

Altabas K, Altabas V, Gulin T. Altabas K, et al. Acta Clin Croat. 2016 Dec;55(4):663-666. doi: 10.20471/acc.2016.55.04.20. Acta Clin Croat. 2016. PMID: 29117660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year